Hospital Universitario del Tajo, Aranjuez, Madrid, Spain.
Hospital Universitario de Móstoles, Móstoles, Madrid, Spain.
Diagn Pathol. 2021 Nov 20;16(1):106. doi: 10.1186/s13000-021-01168-2.
Microsatellite instability occurs due to a series of mutations in the DNA pairing error repair (Mismatch repair; MMR) genes, which can affect germ cells as occurs in Lynch syndrome, whose patients are at high risk of developing multiple cancers. The loss of MMR protein is commonly determined by immunohistochemical studies. Although the relation between microsatellite instability and urothelial carcinomas has been widely studied, its evaluation is not currently performed in the analysis of urothelial carcinomas.
In this study, the microsatellite status of 139 urothelial carcinomas was analyzed and their clinicopathological characteristics were evaluated. We identified that 10.3% (13 patients) of urothelial carcinomas had loss of MMR protein expression (9 MLH1; 5 MSH2; 2 PMS2; 2 PSH6; n = 139).
Results suggest that these tumors occur more frequently in males, are more frequently located in the bladder or ureters, and present a high tumor grade with a papillary histological pattern that does not infiltrate the lamina propria or, in the case of infiltrating tumors, that grows into perivesical tissues.
We identified patients with the aforementioned tumor characteristics as patients with a high probability of presenting loss of MMR protein expression, and consider that only these patients should undergo further immunohistochemical and molecular techniques for proper diagnosis. Therefore, we propose that the clinicopathological characteristics found in the present study could become possible markers to determine which cases should undergo additional tests.
微卫星不稳定性是由于 DNA 配对错误修复(错配修复;MMR)基因的一系列突变引起的,这种突变可影响生殖细胞,就像林奇综合征那样,其患者发生多种癌症的风险很高。MMR 蛋白的缺失通常通过免疫组织化学研究来确定。尽管微卫星不稳定性与尿路上皮癌之间的关系已被广泛研究,但目前在分析尿路上皮癌时并未进行其评估。
在这项研究中,分析了 139 例尿路上皮癌的微卫星状态,并评估了其临床病理特征。我们发现,10.3%(13 例患者)的尿路上皮癌存在 MMR 蛋白表达缺失(9 例 MLH1;5 例 MSH2;2 例 PMS2;2 例 PSH6;n=139)。
结果表明,这些肿瘤更常发生于男性,更常位于膀胱或输尿管,且具有高肿瘤分级、乳头状组织学模式,未浸润固有层,或在浸润性肿瘤的情况下,生长至膀胱周围组织。
我们将具有上述肿瘤特征的患者鉴定为存在 MMR 蛋白表达缺失的高概率患者,并且认为只有这些患者应进一步进行免疫组织化学和分子技术检查以做出正确诊断。因此,我们提出,本研究中发现的临床病理特征可能成为确定哪些病例应进行额外检查的潜在标志物。